1. Home
  2. BBIO vs DPZ Comparison

BBIO vs DPZ Comparison

Compare BBIO & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • DPZ
  • Stock Information
  • Founded
  • BBIO 2015
  • DPZ 1960
  • Country
  • BBIO United States
  • DPZ United States
  • Employees
  • BBIO N/A
  • DPZ N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • DPZ Food Distributors
  • Sector
  • BBIO Health Care
  • DPZ Consumer Discretionary
  • Exchange
  • BBIO Nasdaq
  • DPZ Nasdaq
  • Market Cap
  • BBIO 12.5B
  • DPZ 13.9B
  • IPO Year
  • BBIO 2019
  • DPZ 2004
  • Fundamental
  • Price
  • BBIO $71.90
  • DPZ $416.82
  • Analyst Decision
  • BBIO Strong Buy
  • DPZ Buy
  • Analyst Count
  • BBIO 19
  • DPZ 22
  • Target Price
  • BBIO $74.79
  • DPZ $487.64
  • AVG Volume (30 Days)
  • BBIO 2.4M
  • DPZ 527.6K
  • Earning Date
  • BBIO 10-29-2025
  • DPZ 10-14-2025
  • Dividend Yield
  • BBIO N/A
  • DPZ 1.67%
  • EPS Growth
  • BBIO N/A
  • DPZ 5.20
  • EPS
  • BBIO N/A
  • DPZ 17.13
  • Revenue
  • BBIO $353,780,000.00
  • DPZ $4,848,168,000.00
  • Revenue This Year
  • BBIO $123.32
  • DPZ $5.71
  • Revenue Next Year
  • BBIO $73.46
  • DPZ $6.43
  • P/E Ratio
  • BBIO N/A
  • DPZ $24.27
  • Revenue Growth
  • BBIO 62.46
  • DPZ 3.92
  • 52 Week Low
  • BBIO $25.34
  • DPZ $392.89
  • 52 Week High
  • BBIO $72.26
  • DPZ $500.55
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 71.58
  • DPZ 55.37
  • Support Level
  • BBIO $64.41
  • DPZ $397.07
  • Resistance Level
  • BBIO $67.71
  • DPZ $413.65
  • Average True Range (ATR)
  • BBIO 2.80
  • DPZ 9.12
  • MACD
  • BBIO 0.35
  • DPZ 2.04
  • Stochastic Oscillator
  • BBIO 95.73
  • DPZ 78.82

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About DPZ Domino's Pizza Inc

Domino's is a restaurant operator and franchiser with over 21,500 global stores across more than 90 international markets at the end of the second quarter of 2025. The firm generates revenue through the sales of pizza, wings, salads, sandwiches, and desserts at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's US and Canadian restaurants. With roughly $19.2 billion in 2024 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Little Caesars, and Papa John's.

Share on Social Networks: